Efficacy of concurrent radiotherapy in patients with locally advanced rectal cancer and synchronous metastasis receiving systemic therapy

BackgroundNeoadjuvant chemoradiotherapy followed by total mesorectal excision is the standard treatment for patients with nonmetastatic locally advanced rectal cancer (LARC). However, for patients with LARC and synchronous metastasis, the optimal treatment strategy and sequence remain inconclusive....

Full description

Bibliographic Details
Main Authors: Tzu-Chieh Yin, Po-Jung Chen, Yung-Sung Yeh, Ching-Chun Li, Yen-Cheng Chen, Wei-Chih Su, Tsung-Kun Chang, Ching-Wen Huang, Chun-Ming Huang, Hsiang-Lin Tsai, Jaw-Yuan Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-03-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2023.1099168/full
_version_ 1797856210311970816
author Tzu-Chieh Yin
Tzu-Chieh Yin
Tzu-Chieh Yin
Po-Jung Chen
Yung-Sung Yeh
Yung-Sung Yeh
Yung-Sung Yeh
Ching-Chun Li
Ching-Chun Li
Yen-Cheng Chen
Yen-Cheng Chen
Wei-Chih Su
Wei-Chih Su
Tsung-Kun Chang
Tsung-Kun Chang
Tsung-Kun Chang
Ching-Wen Huang
Ching-Wen Huang
Chun-Ming Huang
Chun-Ming Huang
Chun-Ming Huang
Chun-Ming Huang
Hsiang-Lin Tsai
Hsiang-Lin Tsai
Jaw-Yuan Wang
Jaw-Yuan Wang
Jaw-Yuan Wang
Jaw-Yuan Wang
Jaw-Yuan Wang
Jaw-Yuan Wang
author_facet Tzu-Chieh Yin
Tzu-Chieh Yin
Tzu-Chieh Yin
Po-Jung Chen
Yung-Sung Yeh
Yung-Sung Yeh
Yung-Sung Yeh
Ching-Chun Li
Ching-Chun Li
Yen-Cheng Chen
Yen-Cheng Chen
Wei-Chih Su
Wei-Chih Su
Tsung-Kun Chang
Tsung-Kun Chang
Tsung-Kun Chang
Ching-Wen Huang
Ching-Wen Huang
Chun-Ming Huang
Chun-Ming Huang
Chun-Ming Huang
Chun-Ming Huang
Hsiang-Lin Tsai
Hsiang-Lin Tsai
Jaw-Yuan Wang
Jaw-Yuan Wang
Jaw-Yuan Wang
Jaw-Yuan Wang
Jaw-Yuan Wang
Jaw-Yuan Wang
author_sort Tzu-Chieh Yin
collection DOAJ
description BackgroundNeoadjuvant chemoradiotherapy followed by total mesorectal excision is the standard treatment for patients with nonmetastatic locally advanced rectal cancer (LARC). However, for patients with LARC and synchronous metastasis, the optimal treatment strategy and sequence remain inconclusive. In the present study, we evaluated the efficacy and safety of concurrent radiotherapy in patients with de novo metastatic rectal cancer who received chemotherapy and targeted therapy.MethodsWe retrospectively reviewed the data of 63 patients with LARC and synchronous metastasis who received intensive therapy at the study hospital between April 2015 and November 2018. The included patients were divided into two groups: RT-CT, those who received systemic chemotherapy with targeted therapy and concurrent radiotherapy (for primary rectal cancer), and CT, those who received only systemic chemotherapy with targeted therapy.ResultsTreatment response was better in the RT-CT group than in the CT group. The rate of primary tumor resection (PTR) was higher in the RT-CT group than in the CT group (71.4% and 42.9%, respectively; P = .0286). The RT-CT group exhibited considerably longer local recurrence-free survival (P = .0453) and progression-free survival (PFS; from 13.3 to 22.5 months) than did the CT group (P = .0091); however, the groups did not differ in terms of overall survival (OS; P = .49). Adverse events were almost similar between the groups, except frequent diarrhea, the prevalence of which was higher in the RT-CT group than in the CT group (59.5% and 23.8%, respectively; P = .0075).ConclusionsIn the era of biologics, radiotherapy may increase the resectability of primary rectal tumors, reducing the risk of locoregional failure and prolonging PFS. Concurrent pelvic radiotherapy may not substantially improve OS, which is indicated by metastasis. Hence, the resection of the distant metastases may be essential for improving long-term OS. To further determine the efficacy of concurrent radiotherapy, additional prospective, randomized studies must combine preoperative pelvic radiotherapy with PTR and metastectomy to treat patients with stage IV LARC.
first_indexed 2024-04-09T20:37:53Z
format Article
id doaj.art-5d7444be5dec42e79094795e633f37cd
institution Directory Open Access Journal
issn 2234-943X
language English
last_indexed 2024-04-09T20:37:53Z
publishDate 2023-03-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj.art-5d7444be5dec42e79094795e633f37cd2023-03-30T07:20:58ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2023-03-011310.3389/fonc.2023.10991681099168Efficacy of concurrent radiotherapy in patients with locally advanced rectal cancer and synchronous metastasis receiving systemic therapyTzu-Chieh Yin0Tzu-Chieh Yin1Tzu-Chieh Yin2Po-Jung Chen3Yung-Sung Yeh4Yung-Sung Yeh5Yung-Sung Yeh6Ching-Chun Li7Ching-Chun Li8Yen-Cheng Chen9Yen-Cheng Chen10Wei-Chih Su11Wei-Chih Su12Tsung-Kun Chang13Tsung-Kun Chang14Tsung-Kun Chang15Ching-Wen Huang16Ching-Wen Huang17Chun-Ming Huang18Chun-Ming Huang19Chun-Ming Huang20Chun-Ming Huang21Hsiang-Lin Tsai22Hsiang-Lin Tsai23Jaw-Yuan Wang24Jaw-Yuan Wang25Jaw-Yuan Wang26Jaw-Yuan Wang27Jaw-Yuan Wang28Jaw-Yuan Wang29Division of General and Digestive Surgery, Department of Surgery, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, TaiwanDepartment of Surgery, Kaohsiung Municipal Tatung Hospital, Kaohsiung Medical University, Kaohsiung, TaiwanDivision of Colorectal Surgery, Department of Surgery, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, TaiwanDivision of Colorectal Surgery, Department of Surgery, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, TaiwanDivision of Trauma and Surgical Critical Care, Department of Surgery, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, TaiwanDepartment of Emergency Medicine, Faculty of Post-Baccalaureate Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, TaiwanGraduate Institute of Injury Prevention and Control, College of Public Health, Taipei Medical University, Taipei, TaiwanDivision of General and Digestive Surgery, Department of Surgery, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, TaiwanDepartment of Surgery, Kaohsiung Municipal Hsiaokang Hospital, Kaohsiung, TaiwanDivision of Colorectal Surgery, Department of Surgery, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, TaiwanGraduate Institute of Clinical Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, TaiwanDivision of Colorectal Surgery, Department of Surgery, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, TaiwanGraduate Institute of Clinical Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, TaiwanDivision of Colorectal Surgery, Department of Surgery, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, TaiwanGraduate Institute of Clinical Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, TaiwanDepartment of Surgery, Faculty of Post-Baccalaureate Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, TaiwanDivision of Colorectal Surgery, Department of Surgery, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan0Department of Surgery, Faculty of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan1Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan2Department of Radiation Oncology, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan3Department of Radiation Oncology, Faculty of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan4Department of Radiation Oncology, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung Medical University, Kaohsiung, TaiwanDivision of Colorectal Surgery, Department of Surgery, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan0Department of Surgery, Faculty of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, TaiwanDivision of Colorectal Surgery, Department of Surgery, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, TaiwanGraduate Institute of Clinical Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan0Department of Surgery, Faculty of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan1Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan5Center for Cancer Research, Kaohsiung Medical University, Kaohsiung, Taiwan6Pingtung Hospital, Ministry of Health and Welfare, Pingtung, TaiwanBackgroundNeoadjuvant chemoradiotherapy followed by total mesorectal excision is the standard treatment for patients with nonmetastatic locally advanced rectal cancer (LARC). However, for patients with LARC and synchronous metastasis, the optimal treatment strategy and sequence remain inconclusive. In the present study, we evaluated the efficacy and safety of concurrent radiotherapy in patients with de novo metastatic rectal cancer who received chemotherapy and targeted therapy.MethodsWe retrospectively reviewed the data of 63 patients with LARC and synchronous metastasis who received intensive therapy at the study hospital between April 2015 and November 2018. The included patients were divided into two groups: RT-CT, those who received systemic chemotherapy with targeted therapy and concurrent radiotherapy (for primary rectal cancer), and CT, those who received only systemic chemotherapy with targeted therapy.ResultsTreatment response was better in the RT-CT group than in the CT group. The rate of primary tumor resection (PTR) was higher in the RT-CT group than in the CT group (71.4% and 42.9%, respectively; P = .0286). The RT-CT group exhibited considerably longer local recurrence-free survival (P = .0453) and progression-free survival (PFS; from 13.3 to 22.5 months) than did the CT group (P = .0091); however, the groups did not differ in terms of overall survival (OS; P = .49). Adverse events were almost similar between the groups, except frequent diarrhea, the prevalence of which was higher in the RT-CT group than in the CT group (59.5% and 23.8%, respectively; P = .0075).ConclusionsIn the era of biologics, radiotherapy may increase the resectability of primary rectal tumors, reducing the risk of locoregional failure and prolonging PFS. Concurrent pelvic radiotherapy may not substantially improve OS, which is indicated by metastasis. Hence, the resection of the distant metastases may be essential for improving long-term OS. To further determine the efficacy of concurrent radiotherapy, additional prospective, randomized studies must combine preoperative pelvic radiotherapy with PTR and metastectomy to treat patients with stage IV LARC.https://www.frontiersin.org/articles/10.3389/fonc.2023.1099168/fullmetastatic rectal cancerlocally advanced rectal cancerconcurrent radiotherapyprimary tumor resection (PTR)systemic chemotherapysystemic targeted therapy
spellingShingle Tzu-Chieh Yin
Tzu-Chieh Yin
Tzu-Chieh Yin
Po-Jung Chen
Yung-Sung Yeh
Yung-Sung Yeh
Yung-Sung Yeh
Ching-Chun Li
Ching-Chun Li
Yen-Cheng Chen
Yen-Cheng Chen
Wei-Chih Su
Wei-Chih Su
Tsung-Kun Chang
Tsung-Kun Chang
Tsung-Kun Chang
Ching-Wen Huang
Ching-Wen Huang
Chun-Ming Huang
Chun-Ming Huang
Chun-Ming Huang
Chun-Ming Huang
Hsiang-Lin Tsai
Hsiang-Lin Tsai
Jaw-Yuan Wang
Jaw-Yuan Wang
Jaw-Yuan Wang
Jaw-Yuan Wang
Jaw-Yuan Wang
Jaw-Yuan Wang
Efficacy of concurrent radiotherapy in patients with locally advanced rectal cancer and synchronous metastasis receiving systemic therapy
Frontiers in Oncology
metastatic rectal cancer
locally advanced rectal cancer
concurrent radiotherapy
primary tumor resection (PTR)
systemic chemotherapy
systemic targeted therapy
title Efficacy of concurrent radiotherapy in patients with locally advanced rectal cancer and synchronous metastasis receiving systemic therapy
title_full Efficacy of concurrent radiotherapy in patients with locally advanced rectal cancer and synchronous metastasis receiving systemic therapy
title_fullStr Efficacy of concurrent radiotherapy in patients with locally advanced rectal cancer and synchronous metastasis receiving systemic therapy
title_full_unstemmed Efficacy of concurrent radiotherapy in patients with locally advanced rectal cancer and synchronous metastasis receiving systemic therapy
title_short Efficacy of concurrent radiotherapy in patients with locally advanced rectal cancer and synchronous metastasis receiving systemic therapy
title_sort efficacy of concurrent radiotherapy in patients with locally advanced rectal cancer and synchronous metastasis receiving systemic therapy
topic metastatic rectal cancer
locally advanced rectal cancer
concurrent radiotherapy
primary tumor resection (PTR)
systemic chemotherapy
systemic targeted therapy
url https://www.frontiersin.org/articles/10.3389/fonc.2023.1099168/full
work_keys_str_mv AT tzuchiehyin efficacyofconcurrentradiotherapyinpatientswithlocallyadvancedrectalcancerandsynchronousmetastasisreceivingsystemictherapy
AT tzuchiehyin efficacyofconcurrentradiotherapyinpatientswithlocallyadvancedrectalcancerandsynchronousmetastasisreceivingsystemictherapy
AT tzuchiehyin efficacyofconcurrentradiotherapyinpatientswithlocallyadvancedrectalcancerandsynchronousmetastasisreceivingsystemictherapy
AT pojungchen efficacyofconcurrentradiotherapyinpatientswithlocallyadvancedrectalcancerandsynchronousmetastasisreceivingsystemictherapy
AT yungsungyeh efficacyofconcurrentradiotherapyinpatientswithlocallyadvancedrectalcancerandsynchronousmetastasisreceivingsystemictherapy
AT yungsungyeh efficacyofconcurrentradiotherapyinpatientswithlocallyadvancedrectalcancerandsynchronousmetastasisreceivingsystemictherapy
AT yungsungyeh efficacyofconcurrentradiotherapyinpatientswithlocallyadvancedrectalcancerandsynchronousmetastasisreceivingsystemictherapy
AT chingchunli efficacyofconcurrentradiotherapyinpatientswithlocallyadvancedrectalcancerandsynchronousmetastasisreceivingsystemictherapy
AT chingchunli efficacyofconcurrentradiotherapyinpatientswithlocallyadvancedrectalcancerandsynchronousmetastasisreceivingsystemictherapy
AT yenchengchen efficacyofconcurrentradiotherapyinpatientswithlocallyadvancedrectalcancerandsynchronousmetastasisreceivingsystemictherapy
AT yenchengchen efficacyofconcurrentradiotherapyinpatientswithlocallyadvancedrectalcancerandsynchronousmetastasisreceivingsystemictherapy
AT weichihsu efficacyofconcurrentradiotherapyinpatientswithlocallyadvancedrectalcancerandsynchronousmetastasisreceivingsystemictherapy
AT weichihsu efficacyofconcurrentradiotherapyinpatientswithlocallyadvancedrectalcancerandsynchronousmetastasisreceivingsystemictherapy
AT tsungkunchang efficacyofconcurrentradiotherapyinpatientswithlocallyadvancedrectalcancerandsynchronousmetastasisreceivingsystemictherapy
AT tsungkunchang efficacyofconcurrentradiotherapyinpatientswithlocallyadvancedrectalcancerandsynchronousmetastasisreceivingsystemictherapy
AT tsungkunchang efficacyofconcurrentradiotherapyinpatientswithlocallyadvancedrectalcancerandsynchronousmetastasisreceivingsystemictherapy
AT chingwenhuang efficacyofconcurrentradiotherapyinpatientswithlocallyadvancedrectalcancerandsynchronousmetastasisreceivingsystemictherapy
AT chingwenhuang efficacyofconcurrentradiotherapyinpatientswithlocallyadvancedrectalcancerandsynchronousmetastasisreceivingsystemictherapy
AT chunminghuang efficacyofconcurrentradiotherapyinpatientswithlocallyadvancedrectalcancerandsynchronousmetastasisreceivingsystemictherapy
AT chunminghuang efficacyofconcurrentradiotherapyinpatientswithlocallyadvancedrectalcancerandsynchronousmetastasisreceivingsystemictherapy
AT chunminghuang efficacyofconcurrentradiotherapyinpatientswithlocallyadvancedrectalcancerandsynchronousmetastasisreceivingsystemictherapy
AT chunminghuang efficacyofconcurrentradiotherapyinpatientswithlocallyadvancedrectalcancerandsynchronousmetastasisreceivingsystemictherapy
AT hsianglintsai efficacyofconcurrentradiotherapyinpatientswithlocallyadvancedrectalcancerandsynchronousmetastasisreceivingsystemictherapy
AT hsianglintsai efficacyofconcurrentradiotherapyinpatientswithlocallyadvancedrectalcancerandsynchronousmetastasisreceivingsystemictherapy
AT jawyuanwang efficacyofconcurrentradiotherapyinpatientswithlocallyadvancedrectalcancerandsynchronousmetastasisreceivingsystemictherapy
AT jawyuanwang efficacyofconcurrentradiotherapyinpatientswithlocallyadvancedrectalcancerandsynchronousmetastasisreceivingsystemictherapy
AT jawyuanwang efficacyofconcurrentradiotherapyinpatientswithlocallyadvancedrectalcancerandsynchronousmetastasisreceivingsystemictherapy
AT jawyuanwang efficacyofconcurrentradiotherapyinpatientswithlocallyadvancedrectalcancerandsynchronousmetastasisreceivingsystemictherapy
AT jawyuanwang efficacyofconcurrentradiotherapyinpatientswithlocallyadvancedrectalcancerandsynchronousmetastasisreceivingsystemictherapy
AT jawyuanwang efficacyofconcurrentradiotherapyinpatientswithlocallyadvancedrectalcancerandsynchronousmetastasisreceivingsystemictherapy